Quick Takeaways
- JANUS HENDERSON GROUP PLC filed SCHEDULE 13G/A for MAZE THERAPEUTICS, INC. Common Stock (MAZE).
- Disclosed ownership: 6%.
- Date of event: 31 Mar 2025.
JANUS HENDERSON GROUP PLC - 31 Mar 2025 SCHEDULE 13G/A Report for MAZE THERAPEUTICS, INC. Common Stock (MAZE)
- Filing Manager
- JANUS HENDERSON GROUP PLC
- Reporting Manager
- JANUS HENDERSON GROUP PLC
- Security
- MAZE THERAPEUTICS, INC. Common Stock
- Symbol
- MAZE
- Shares outstanding
- 43,751,483 shares
- Disclosed Ownership
- 2,625,089 shares
- Ownership
- 6%
- Form type
- SCHEDULE 13G/A
- Filing time
- 14 Aug 2025, 11:46:43 UTC
- Date of event
- 31 Mar 2025
- Next filing
- 14 Nov 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"JANUS HENDERSON GROUP PLC disclosed 6% ownership in MAZE THERAPEUTICS, INC. Common Stock (MAZE) on 31 Mar 2025."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 14 Aug 2025, 11:46.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Source Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting Managers (1)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| JANUS HENDERSON GROUP PLC | 6% | 2,625,089 | 0 | 2,625,089 | Kristin Mariani | Head of North America Compliance, CCO |